Previous Close | 85.14 |
Open | 85.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 83.90 - 85.32 |
52 Week Range | 76.45 - 106.66 |
Volume | |
Avg. Volume | 1,821,982 |
Market Cap | 108.529B |
Beta (5Y Monthly) | 0.41 |
PE Ratio (TTM) | 15.81 |
EPS (TTM) | 5.37 |
Earnings Date | Apr 27, 2023 |
Forward Dividend & Yield | 3.33 (3.91%) |
Ex-Dividend Date | May 06, 2022 |
1y Target Est | 102.70 |
Subscribe to Yahoo Finance Plus to view Fair Value for SAN.PA
Image source: The Motley Fool. Sanofi (NASDAQ: SNY)Q4 2022 Earnings CallFeb 03, 2023, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Eva Schaefer-Jansen May cause actual results to differ materially.
Regeneron Pharma beat quarterly forecasts Friday, but its partner Sanofi posted a mixed report. Regeneron stock rose as SNY stock toppled.
Regeneron (REGN) tops earnings and sales estimates for the fourth quarter. However, sales of the lead drug Eylea decline year over year.